• 제목/요약/키워드: dexamethasone suppression test

검색결과 10건 처리시간 0.017초

조증 및 정신분열병 환자에서 덱사메사손/인슐린-유도성 저혈당 병합검사 (Combined Dexamethasone/Insulin-induced Hypoglycemic Test in Manic and Schizophrenic Patients)

  • 성시용;박철수;손진욱
    • 생물정신의학
    • /
    • 제4권2호
    • /
    • pp.272-278
    • /
    • 1997
  • Many investigators are trying to elucidate the pathogenesis of psychiatric disorders on the basis of neuroendocrine responses to stimulation or perturbation. Dexamethasone(DEX) suppression has been the most widely utilized as the prototypical challenge test. Dexamethasone suppression test(DST) has proven to be valuable in diagnosing the depressive spectrum disorder. Reported specificity of diagnosis of depression is relatively high, but sensitivity is limited. Some researchers used the combination of dexamethasone and corticotropin releasing hormone(CRH) in order to improve the sensitivity. They reported that combined DEX/CRH test is more sensitive than DST alone. In this study the authors modified the DEX/CRH test, i.e., we administered the insulin instead of CRH. Total subjects were 28(7 normal controls, 10 manic patients, 11 schizophrenic patients). Subjects were taken DEX(1.5mg p.o.) at 11 p.m., insulin 16 hours later(0.1 unit/kg i.v.). Five blood samples for the determination of cortisol and ACTH were serially drawn at 15 minute interval. The results are as followings : 1) The cortisol and ACTH levels of manic subjects increased following insulin administration. Manic subjects showed higher levels of cortisol and ACTH than schizophrenic and normal control subjects. The cortisol and ACTH levels of schizophrenic and normal control subjects did not show gross changes. 2) The sensitivity of the test was lower than that of reported DEX/CRH test.

  • PDF

ELISA를 이용한 cortisol 측정법의 정립 및 임상적 응용 (Development of ELISA for cortisol and it's application to clinical use)

  • 나기정;이창우
    • 대한수의학회지
    • /
    • 제36권3호
    • /
    • pp.731-741
    • /
    • 1996
  • ELISA kit for cortisol was developed and then evaluated. Polyclonal antihydrocortisone-3-(o-carboxymethyl)oxime BSA rabbit serum was used to coat the 96-well microplates. The minimum detection limit of the kit was 250pg of cortisol per milliliter. The within-run variation and the day to day variation of the ELISA system were 2.0 and 5.9 at maximum, respectively. The kit was used to determine whether salivary cortisol concentration could replace blood cortisol concentration in dexamathasone suppression test of dogs. Changes of cortisol concentration were measured in serum or saliva after intravenous administration of 0.01mg of dexamethasone per kilogram of body weight. Blood alone, saliva alone or both were collected at 0, 30, 60, 120, 240, and 360 minutes after injection of dexamethasone. The change in blood cortisol concentration was found to be suitable in dexamathasone suppression test of dogs, but the change in salivary cortisol concentration was not. The kit was also used to determine whether salivary cortisol concentration could be a stress index as well as blood cortisol concentration in dogs. Two types of trial were performed to estimate the stress either by blood or salivary cortisol concentration. The first trial was stress experiment by intravenous injection of 0.2IU of PZI-insulin per kilogram body weight. Either blood alone or saliva alone was collected at 0, 30, 60, and 90 minutes after insulin administration. Both blood and salivary cortisol concentration were found to be suitable index in estimating stress from hypoglycemia by injection of insulin. The second trial was stress experiment by electrical irritation. The dogs were irritated with anti-bark device for 10 seconds. Blood was collected before and at 2 and 5 minutes after electrical irritation. Saliva was collected before and at 3 and 6 minutes after electrical irritation. The blood cortisol concentration, but not the salivary cortisol concentration was found to be suitable index in estimating stress from electrical irritation. Cushing syndrome in a dog was also successfully diagnosed with this kit.

  • PDF

뇌졸중 환자에서 Dexamethasone 억제검사의 의의 (Significance of Dexamethasone Suppression Test in Patients with Stroke)

  • 김욱년;김성민;기병수;박미영;하정상;변영주
    • Journal of Yeungnam Medical Science
    • /
    • 제11권1호
    • /
    • pp.63-71
    • /
    • 1994
  • 뇌졸중이 시상하부-뇌하수체-부신축에 미치는 영향을 조사하기 위해 1992년 6월 1일부터 1993년 6월 30일까지 영남대학교 의과대학 부속병원 신경과에 입원한 뇌경색 42례, 뇌출혈 20례 등 총 62례 환자대상군과 대조군 21례를 대상으로 뇌졸중의 각 유형, 병변부위, 병변크기, 운동장애정도, 연령 및 성별 등이 DST결과에 어떤 영향을 미치는지 조사하여 다음과 같은 성적을 얻었다. 뇌경색군에서 혈청 cortisol기저치가 대조군보다 유의하게 높았고 (p<0.01), DST 비억제반응의 빈도는 뇌졸중군에서 대조군보다 유의하게 높았다(p<0.05). 뇌졸중군 중에서 좌측 대뇌반구의 병변이 DST 비억제반응의 빈도가 유의하게 높았다(p<0.01). 뇌졸중의 병변크기가 심할수록 DST 비억제반응의 빈도가 유의하게 높았으나 (P<0.01) 뇌졸중의 각 유형, 운동장애 정도, 연령 및 성별등은 DST 비억제반응의 빈도와 유의한 차이는 없었다. 이로 미루어 볼때 뇌졸중이 HPA축에 영향을 미침을 알 수 있고, 뇌졸중 유형중에는 뇌경색이 가장 많은 장애를 초래하며, 뇌졸중의 병변부위에 따라서는 좌측 대뇌반구가 가장 많은 장애를 야기하며, 병변이 클수록 더 많은 장애를 초래함을 알 수 있어 뇌졸중후 나타나는 우울증등의 시상하부와 연관된 환자에게는 항 우울제투여로 임상효과를 기대할 수 있고 향후 뇌척수액의 신경전달물질 검사 및 뇨의 catecholamine대사산물 측정 등 지속적 연구가 필요할 것으로 사료된다.

  • PDF

Pituitary Pars Intermedia Dysfunction with Laminitis in a Horse

  • Lee, Eun-bee;Chun, Yong-woo;Park, Kyung-won;Kang, Tae-young;Seo, Jong-pil
    • 한국임상수의학회지
    • /
    • 제38권1호
    • /
    • pp.41-44
    • /
    • 2021
  • Pituitary pars intermedia dysfunction (PPID), often referred to as equine Cushing's disease, is a common endocrine disorder often diagnosed in older horses. A 13-year-old 460 kg Warmblood gelding showed clinical signs suggestive of PPID, including hypertrichosis, fat redistribution, polyuria and polydipsia (PU/PD), and weight loss. Physical examination, complete blood cell count, and serum chemistry results were normal. However, dexamethasone suppression and plasma adrenocorticotropic hormone (ACTH) level tests confirmed PPID. Three months after the confirmed diagnosis, the horse was referred again with symptoms of laminitis. Radiography and venography were performed to evaluate the laminitis severity level. However, the foot condition continued to worsen, and the horse was eventually euthanized. The purpose of this case report is to describe clinical signs and diagnosis of PPID with laminitis.

개에서 자연발생한 뇌하수체 의존성 부신피질기능 항진증의 치료 및 관리 (Mitotane Therapy and Management of Naturally Occurring Pituitary Dependent Hyperadrenocorticism (PDH) in a Dog)

  • Song, Jae-won;Park, Hee-Myung
    • 한국임상수의학회지
    • /
    • 제20권2호
    • /
    • pp.233-236
    • /
    • 2003
  • 10년령의 중성화 되지 않은 암컷의 요크셔테리어가 건국대학교 부속 동물병원으로 진료가 의뢰되어 왔다. 환축은 얼굴과 복벽에 심각한 괴사성 피부염을 보였으며 또한 다음다뇨 및 다식증을 나타내었다. 병력청취와 신체검사, CBC, 혈액생화학 검사를 토대로 하여 부신피질기능항진증을 의심하였고, 나아가 ACTH 자극시험을 통하여 쿠싱증후 군이 확진되었다. 또한, High Dose Dexamethasone Suppression lest (HDDST)극 통하여 뇌하수체 의존성 부신피질 기능 항진증임을 알 수 있었다. Mitotane을 이용한 치료가 개시된후 심자한 피부문제와 PUPD등의 임상증상들이 개선되었다. 그 후 mitotane 처치가 적절히 이루어지고 잇는가를 검증하기 위해 ACTH의 추가적인 검사가 수행되었다. 이 임상증례는 심각한 피부문제를 가지고 있던 환축이 오진단되고 치료의 핵심을 찾지못해 1년 이상 지속된 환축이 mitotane을 이용하여 성공적으로 치료되어 유지되고 있음을 보여주는 증례이다.

우울증 아형들의 이해 (The Understanding of Depression Subtypes)

  • 한창환;류성곤
    • 생물정신의학
    • /
    • 제8권1호
    • /
    • pp.20-36
    • /
    • 2001
  • 우울증으로 고통받는 많은 환자들에서 보이는 다양항 양상과 다양한 경과를 자주 접하면서 분류를 어떻게 하여야 임상적으로 유용한가 의문을 가지게 된다. 이에 저자들은 우울증의 아형 평가의 필요성과 평가도구들을 문헌을 통하여 고찰하였다. 원래부터 이들이 이질적인 집단으로 구성되어 있는지, 하나의 유전적 소인이 있어 개인에 따라서 병의 진행 시기에 따라서 여러 우울증의 spectrum으로 표현되는 것인지 문제가 제기되어 왔지만, 현재로서는 분명히 알 수 없다. 저자들은 먼저 "우울증 스펙트럼" "양극성 우울과 단극성 우울이 공통의 하나의 유전적 인자를 가지는가" "양극성 스펙트럼 장애"등 강한 주장들이 있어 문헌 고찰을 통해서 알아보았다. 그리고, 최근 생물학적인 연구로부터 나온 세로토닌 관련 우울증 가설을 알아보았다. 이 우울증 가설(SeCA depression)은 조기 모성 분리 혹은 모성 박탈 같은 유년시절의 부정적 경험, 불안, 공격성, co-rtisol 증가, cortisol flattening, DST 양성, 스트레스 사건, CRF 상승, 5HIAA저하 등을 연결하여 우울증의 역동을 쉽게 설명하였고 생물-심리-사회적 접근을 가능하게끔 하는 우울증의 모델이다. 둘째로 고전적인 생물학적 지표 즉 DST, TRH 자극 검사, 및 뇨 MHPG 검사 결과에 따르는 우울증 아형을 구분하고 특징을 살펴보았고 이들의 역사적이고 임상적인 의미를 알아보았다. 그밖에 APOE epsilon 4 allele, 기질-성격이론(Temperament Character Inventory : TCI) 심박동 변이도(heart rate variability : HRV) 같은 요인들을 비롯하여 잘 알려진 증상이나 진단으로 분류된 아형들을 조사하여 임상적인 의미를 찾아보았다.

  • PDF

뇌하수체 의존성 부신피질기능항진증 이환견의 Trilostane 치료 1례 (Trilostane Treatment in a Dog with Pituitary-Dependent Hyperadrenocorticism)

  • 임영환;이정연;조성남;박성준;최호정;이영원;송근호
    • 한국임상수의학회지
    • /
    • 제23권2호
    • /
    • pp.202-206
    • /
    • 2006
  • A 7-year-old, spayed female, Yorkshire terrier dog with polyuria/polydipsia (PU/PD), interdigital edema, pruritus and abdominal enlargement was referred to the Veterinary Medical Teaching Hospital of the present university. Pituitary-dependent hyperadrenocortisim (PDH) was diagnosed by clinical signs, physical examination, laboratory examination (complete blood count, serum chemistry, urinalysis, ACTH stimulation test and high dose dexamethasone suppression test) and diagnostic imaging (radiography, ultrasonography and computed tomography). Clinical signs were improved after trilostane treatment, and maintenance therapy with trilostane still continued after successful induction therapy. Trilostane can be used as an alternative to mitotane therapy in hyperadrenocortisim in dogs.

나비굴경유 수술을 통해 완치된 뇌하수체 거대선종에 동반된 쿠싱병 1예 (Treatment of Cushing's disease with macroadenoma through transsphenoidal surgery)

  • 이상아;문재철
    • Journal of Medicine and Life Science
    • /
    • 제18권1호
    • /
    • pp.16-19
    • /
    • 2021
  • Cushing's disease (CD) is a rare illness characterized by chronic hypercortisolism secondary to the overproduction of adrenocorticotropic hormone by a pituitary adenoma, which is associated with a high risk of developing serious complications, such as diabetes mellitus, cardiovascular disease, and emotional disorders. Endoscopic transsphenoidal surgery is performed for the treatment of CD, and was initially preferred over other types of treatments. However, the recurrence after pituitary surgery for CD is a common problem after an initial successful surgery. In microadenomas, the remission rates were higher than those of macroadenoma. This patient had a giant tumor that was greater than 4 cm in length on sella magnetic resonance imaging, and panhypopituitarism was detected using a combined pituitary stimulation test. After transsphenoidal surgery, the patient required temporary hormone replacement for a short period of time. After 1 year, he showed a normal cortisol response on the overnight dexamethasone suppression test and low morning cortisol levels. Therefore, we indicated that the patient was cured of giant macroadenoma with panhypopituitarism before surgery, and thus, reported this case.

Bioequivalence Study of Hydrocortisone Tablets while Secretion of Endogenous Cortisol Suppressed

  • Ok, Tae-Suk;Lee, Kyoung-Jin;Shin, Young-Hee
    • Biomolecules & Therapeutics
    • /
    • 제16권3호
    • /
    • pp.255-260
    • /
    • 2008
  • The purpose of this study was to evaluate the bioequivalence of the test (Daewoo Hydrocortisone 10 mg, Daewoo Pharm. Co., Busan, Korea) and reference (Jenapharm Hydrocortisone 10 mg, JayTech Biogen, Seoul, Korea) hydrocortisone tablets. Twenty-four healthy male Korean volunteers were divided into two groups with a randomized $2{\times}2$ cross-over design. In order to suppress the endogenous cortisol secretion, a single oral dose of Dexamethasone (4 mg) was administered 10 hr prior to hydrocortisone administration. Blood samples were withdrawn for 10 hr at the predetermined intervals after a single oral dose of hydrocortisone (20 mg). The serum concentration of hydrocortisone was analyzed by HPLC/UV using a column switching method after liquid-liquid extraction process. The pharmacokinetic parameters ($AUC_{0{\sim}10hr}$, $C_{max}$, and $T_{max}$) of the test and reference hydrocortisone tablets were determined while the secretion of endogenous cortisol was being suppressed. The pharmacokinetic parameters of the test tablet were not statistically different from those of the reference tablet at ex value was 0.05. The 90% confidence intervals for the average ratio (test/reference) of $AUC_{0{\sim}10hr}$ and $C_{max}$ were within the Korea Food and Drug Administration acceptance range of 0.80-1.25 ($0.89{\sim}0.99$ and $0.86{\sim}0.99$ for $AUC_{0{\sim}10hr}$ and $C_{max}$, respectively). Therefore it was concluded that the test tablet, Daewoo Hydrocortisone tablet was bioequivalent to the reference tablet, Jenapharm Hydrocortisone tablet.

개에서 신성 당뇨 일례 (Renal Glucosuria in a Dog)

  • 강지훈;조민행;김민준;장동우;나기정;양만표
    • 한국임상수의학회지
    • /
    • 제22권4호
    • /
    • pp.420-423
    • /
    • 2005
  • A 2-year-old 16-kg, intact female lindo was presented with weight loss and poor hair coat. Abnormal serum biochemical values included mild hypokalemia (3.9 mmol/L, reference range 4.37 to 5.35 mmol/L) and mild hyperglycemia (124 mg/dl, reference range 65 to 118 mg/dl). in the complete blood count and diagnostic imaging examination, abnormal changes wer not seen. The analysis of urine sample obtained from cystocentesis revealed glucosuria (> 100 mg/dl) and mild proteinuria. Repeated analysis after admission showed persistent glucosuria and hypokalemia. But blood glucose values did not exceed the renal threshold fur glucose reabsorption. To differentiate cause of the glucosuria, the glucose tolerance test and the low-dosage dexamethasone suppression test were indicated. Results of both tests were normal. In addition, the serum total thyroxine $(T_4)$ value was within normal range. The arterial blood gas analysis showed no remarkable changes. The fractional reabsorption rates of amino acids and phosphorus were calculated above $97\%$. Based on these findings, the dog was diagnosed as renal glucosuria due to proximal renal tubular dysfunction. But this persistent renal glucosuria with hypokalemia may be the initial sign of Fanconi's syndrome or proximal renal tubular acidosis.